Monday, 6 November 2017

Drug Interactions of Antiplatelets (Part 6):


Drug Interactions of Vorapaxar:



More Presentations from Naina Mohamed, PhD

©   Vorapaxar is an antiplatelet drug and it is the antagonist of Protease activated receptor-1 (PAR-1) (Thrombin Receptor).

©   Vorapaxar is useful in the secondary prevention of atherothrombotic events occurring in patients with a history of myocardial infarction or peripheral arterial disease.

©   Mechanism of action of Vorapaxar:



©   Vorapaxar is a substrate of CYP3A4 enzyme and its exposure is expected to be elevated by CYP3A4 inhibitors such as…

Ø Ketoconazole

Ø Itraconazole

Ø Posaconazole

Ø Clarithromycin

Ø Nefazodone

Ø Ritonavir

©    CYP3A4 inducers decrease Vorapaxar exposure which include…

Ø Rifampin

©   Drug interactions can result in significant morbidity and mortality and thus minimizing the risk for drug interactions should be a goal in drug therapy.

©   The patients on antiplatelet therapy should bring a list of all of the drugs they are taking including prescription drugs, over-the-counter drugs, and any supplements, herbal or otherwise, during their visit to the doctor or pharmacist.

©   The risk of adverse effects could be reduced by healthcare professionals through the screening, education, and follow up on suspected drug interactions.

©   If possible, the patients are recommended to fill all their prescriptions at one pharmacy.

©   Pharmacists can play a crucial role in identifying possible drug interactions by asking patients about their herbal and other alternative medicine product use.

No comments:

Post a Comment

Drug Interactions of Thiazide Diuretics:

https://www.researchgate.net/publication/342864519_Pharmacodynamic_interactions_of_thiazide_diuretics http://www.ijmdc.com/?mno=51031...